OSE Immunotherapeutics SA(DE:6OP)
€1.68+0.03 (+1.57%)
DE:6OP
OSE Immunotherapeutics SA earnings date
€1.68
At close:+0.03 (+1.57%)
OSE Immunotherapeutics SA (6OP) Q2 2021 Earnings Report
1 Followers
DE:6OP Q2 2021 EPS Results
- Actual EPS
- -EUR 0.64
- Consensus EPS
- EUR 0.13
- Beat/Miss
- Missed by -EUR 0.77
- One Year Ago EPS
- -EUR 0.21
DE:6OP Q2 2021 Revenue Results
- Actual Revenue
- EUR 8.97M
- Expected Revenue
- EUR 10.86M
- Beat/Miss
- Missed by -EUR 1.89M
- YoY Revenue Growth
- +53.45%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 09/21/2021
- Time
- During Market Hours
- Conference Call
- Tuesday, September 21, 2021
DE:6OP Upcoming Earnings
OSE Immunotherapeutics SA's next earnings date is estimated for March 31, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:6OP Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 31, 2027 | 2026 (Q4) | ―- | -1.01 | ― | ― |
| Sep 28, 2026 | 2026 (Q2) | ―- | -0.68 | ― | |
| Apr 30, 2026 | 2025 (Q4) | ―-1.01 | -0.9 | -11.76% (-0.11) | |
| Oct 15, 2025 | 2025 (Q2) | ―-0.68 | 2.63 | -125.99% (-3.31) | |
| Mar 26, 2025 | 2024 (Q4) | ―-0.90 | -0.54 | -67.16% (-0.36) | |
| Sep 26, 2024 | 2024 (Q2) | ―2.63 | -0.64 | 510.63% (+3.27) | |
| Mar 27, 2024 | 2023 (Q4) | ―-0.54 | -0.85 | 36.96% (+0.32) | |
| Sep 27, 2023 | 2023 (Q2) | ―-0.64 | -0.11 | -481.82% (-0.53) | |
| Apr 27, 2023 | 2022 (Q4) | ―-0.85 | -0.29 | -194.83% (-0.56) | |
| Sep 22, 2022 | 2022 (Q2) | ―-0.11 | -0.64 | 82.81% (+0.53) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
